How big is the gpcrtargeting drug market?

This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.The global GPCRtargeting Drug market was valued at US 416 million in 2022 and is anticipated to reach US 485.3 million by 2029 witnessing a CAGR of 2.6 during the forecast period 20232029.

BUY CHAPTERS

Global GPCR-targeting Drug Market Research Report 2023

Code: QYRE-Auto-22I14329

Report

May 2023

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

PerkinElmer Inc

Thermo Fisher Scientific

GPCR-targeting Drug Market Size

The global GPCR-targeting Drug market was valued at US$ 416 million in 2022 and is anticipated to reach US$ 485.3 million by 2029, witnessing a CAGR of 2.6% during the forecast period 2023-2029.

GPCR-targeting Drug Market

GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for GPCR-targeting Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for GPCR-targeting Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for GPCR-targeting Drug in Oncology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of GPCR-targeting Drug include PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam and Corning, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GPCR-targeting Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GPCR-targeting Drug.

The GPCR-targeting Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global GPCR-targeting Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the GPCR-targeting Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of GPCR-targeting Drug Market Report

Report Metric	Details
Report Name	GPCR-targeting Drug Market
Accounted market size in 2022	US$ 416 million
Forecasted market size in 2029	US$ 485.3 million
CAGR	2.6%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Reagent Test Kit Substrate
Segment by Application	Oncology Cardiovascular Central Nervous Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam, Corning, Discoverx, Cisbio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GPCR-targeting Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is GPCR-targeting Drug Market market growing?

Ans: The GPCR-targeting Drug Market market witnessing a CAGR of 2.6% during the forecast period 2023-2029.

What is the GPCR-targeting Drug Market market size in 2029?

Ans: The global GPCR-targeting Drug market was valued at US$ 416 million in 2022 and is anticipated to reach US$ 485.3 million by 2029, witnessing a CAGR of 2.6% during the forecast period 2023-2029.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global GPCR-targeting Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Reagent Test Kit

1.2.3 Substrate

1.3 Market by Application

1.3.1 Global GPCR-targeting Drug Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Central Nervous

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global GPCR-targeting Drug Market Perspective (2018-2029)

2.2 GPCR-targeting Drug Growth Trends by Region

2.2.1 Global GPCR-targeting Drug Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 GPCR-targeting Drug Historic Market Size by Region (2018-2023)

2.2.3 GPCR-targeting Drug Forecasted Market Size by Region (2024-2029)

2.3 GPCR-targeting Drug Market Dynamics

2.3.1 GPCR-targeting Drug Industry Trends

2.3.2 GPCR-targeting Drug Market Drivers

2.3.3 GPCR-targeting Drug Market Challenges

2.3.4 GPCR-targeting Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top GPCR-targeting Drug Players by Revenue

3.1.1 Global Top GPCR-targeting Drug Players by Revenue (2018-2023)

3.1.2 Global GPCR-targeting Drug Revenue Market Share by Players (2018-2023)

3.2 Global GPCR-targeting Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by GPCR-targeting Drug Revenue

3.4 Global GPCR-targeting Drug Market Concentration Ratio

3.4.1 Global GPCR-targeting Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by GPCR-targeting Drug Revenue in 2022

3.5 GPCR-targeting Drug Key Players Head office and Area Served

3.6 Key Players GPCR-targeting Drug Product Solution and Service

3.7 Date of Enter into GPCR-targeting Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4 GPCR-targeting Drug Breakdown Data by Type

4.1 Global GPCR-targeting Drug Historic Market Size by Type (2018-2023)

4.2 Global GPCR-targeting Drug Forecasted Market Size by Type (2024-2029)

5 GPCR-targeting Drug Breakdown Data by Application

5.1 Global GPCR-targeting Drug Historic Market Size by Application (2018-2023)

5.2 Global GPCR-targeting Drug Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America GPCR-targeting Drug Market Size (2018-2029)

6.2 North America GPCR-targeting Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America GPCR-targeting Drug Market Size by Country (2018-2023)

6.4 North America GPCR-targeting Drug Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe GPCR-targeting Drug Market Size (2018-2029)

7.2 Europe GPCR-targeting Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe GPCR-targeting Drug Market Size by Country (2018-2023)

7.4 Europe GPCR-targeting Drug Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific GPCR-targeting Drug Market Size (2018-2029)

8.2 Asia-Pacific GPCR-targeting Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific GPCR-targeting Drug Market Size by Region (2018-2023)

8.4 Asia-Pacific GPCR-targeting Drug Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America GPCR-targeting Drug Market Size (2018-2029)

9.2 Latin America GPCR-targeting Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America GPCR-targeting Drug Market Size by Country (2018-2023)

9.4 Latin America GPCR-targeting Drug Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa GPCR-targeting Drug Market Size (2018-2029)

10.2 Middle East & Africa GPCR-targeting Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa GPCR-targeting Drug Market Size by Country (2018-2023)

10.4 Middle East & Africa GPCR-targeting Drug Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 PerkinElmer

11.1.1 PerkinElmer Company Detail

11.1.2 PerkinElmer Business Overview

11.1.3 PerkinElmer GPCR-targeting Drug Introduction

11.1.4 PerkinElmer Revenue in GPCR-targeting Drug Business (2018-2023)

11.1.5 PerkinElmer Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Detail

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific GPCR-targeting Drug Introduction

11.2.4 Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2018-2023)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Merck

11.3.1 Merck Company Detail

11.3.2 Merck Business Overview

11.3.3 Merck GPCR-targeting Drug Introduction

11.3.4 Merck Revenue in GPCR-targeting Drug Business (2018-2023)

11.3.5 Merck Recent Development

11.4 BD Biosciences

11.4.1 BD Biosciences Company Detail

11.4.2 BD Biosciences Business Overview

11.4.3 BD Biosciences GPCR-targeting Drug Introduction

11.4.4 BD Biosciences Revenue in GPCR-targeting Drug Business (2018-2023)

11.4.5 BD Biosciences Recent Development

11.5 Molecular Devices

11.5.1 Molecular Devices Company Detail

11.5.2 Molecular Devices Business Overview

11.5.3 Molecular Devices GPCR-targeting Drug Introduction

11.5.4 Molecular Devices Revenue in GPCR-targeting Drug Business (2018-2023)

11.5.5 Molecular Devices Recent Development

11.6 Promega

11.6.1 Promega Company Detail

11.6.2 Promega Business Overview

11.6.3 Promega GPCR-targeting Drug Introduction

11.6.4 Promega Revenue in GPCR-targeting Drug Business (2018-2023)

11.6.5 Promega Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Detail

11.7.2 Qiagen Business Overview

11.7.3 Qiagen GPCR-targeting Drug Introduction

11.7.4 Qiagen Revenue in GPCR-targeting Drug Business (2018-2023)

11.7.5 Qiagen Recent Development

11.8 Abcam

11.8.1 Abcam Company Detail

11.8.2 Abcam Business Overview

11.8.3 Abcam GPCR-targeting Drug Introduction

11.8.4 Abcam Revenue in GPCR-targeting Drug Business (2018-2023)

11.8.5 Abcam Recent Development

11.9 Corning

11.9.1 Corning Company Detail

11.9.2 Corning Business Overview

11.9.3 Corning GPCR-targeting Drug Introduction

11.9.4 Corning Revenue in GPCR-targeting Drug Business (2018-2023)

11.9.5 Corning Recent Development

11.10 Discoverx

11.10.1 Discoverx Company Detail

11.10.2 Discoverx Business Overview

11.10.3 Discoverx GPCR-targeting Drug Introduction

11.10.4 Discoverx Revenue in GPCR-targeting Drug Business (2018-2023)

11.10.5 Discoverx Recent Development

11.11 Cisbio

11.11.1 Cisbio Company Detail

11.11.2 Cisbio Business Overview

11.11.3 Cisbio GPCR-targeting Drug Introduction

11.11.4 Cisbio Revenue in GPCR-targeting Drug Business (2018-2023)

11.11.5 Cisbio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

PerkinElmer Inc

Thermo Fisher Scientific

List of Tables

Table 1. Global GPCR-targeting Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Reagent Test Kit

Table 3. Key Players of Substrate

Table 4. Global GPCR-targeting Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 5. Global GPCR-targeting Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global GPCR-targeting Drug Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global GPCR-targeting Drug Market Share by Region (2018-2023)

Table 8. Global GPCR-targeting Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global GPCR-targeting Drug Market Share by Region (2024-2029)

Table 10. GPCR-targeting Drug Market Trends

Table 11. GPCR-targeting Drug Market Drivers

Table 12. GPCR-targeting Drug Market Challenges

Table 13. GPCR-targeting Drug Market Restraints

Table 14. Global GPCR-targeting Drug Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global GPCR-targeting Drug Market Share by Players (2018-2023)

Table 16. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2022)

Table 17. Ranking of Global Top GPCR-targeting Drug Companies by Revenue (US$ Million) in 2022

Table 18. Global 5 Largest Players Market Share by GPCR-targeting Drug Revenue (CR5 and HHI) & (2018-2023)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players GPCR-targeting Drug Product Solution and Service

Table 21. Date of Enter into GPCR-targeting Drug Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global GPCR-targeting Drug Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global GPCR-targeting Drug Revenue Market Share by Type (2018-2023)

Table 25. Global GPCR-targeting Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global GPCR-targeting Drug Revenue Market Share by Type (2024-2029)

Table 27. Global GPCR-targeting Drug Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global GPCR-targeting Drug Revenue Market Share by Application (2018-2023)

Table 29. Global GPCR-targeting Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global GPCR-targeting Drug Revenue Market Share by Application (2024-2029)

Table 31. North America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 32. North America GPCR-targeting Drug Market Size by Country (2018-2023) & (US$ Million)

Table 33. North America GPCR-targeting Drug Market Size by Country (2024-2029) & (US$ Million)

Table 34. Europe GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 35. Europe GPCR-targeting Drug Market Size by Country (2018-2023) & (US$ Million)

Table 36. Europe GPCR-targeting Drug Market Size by Country (2024-2029) & (US$ Million)

Table 37. Asia-Pacific GPCR-targeting Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 38. Asia-Pacific GPCR-targeting Drug Market Size by Region (2018-2023) & (US$ Million)

Table 39. Asia-Pacific GPCR-targeting Drug Market Size by Region (2024-2029) & (US$ Million)

Table 40. Latin America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 41. Latin America GPCR-targeting Drug Market Size by Country (2018-2023) & (US$ Million)

Table 42. Latin America GPCR-targeting Drug Market Size by Country (2024-2029) & (US$ Million)

Table 43. Middle East & Africa GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Middle East & Africa GPCR-targeting Drug Market Size by Country (2018-2023) & (US$ Million)

Table 45. Middle East & Africa GPCR-targeting Drug Market Size by Country (2024-2029) & (US$ Million)

Table 46. PerkinElmer Company Detail

Table 47. PerkinElmer Business Overview

Table 48. PerkinElmer GPCR-targeting Drug Product

Table 49. PerkinElmer Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 50. PerkinElmer Recent Development

Table 51. Thermo Fisher Scientific Company Detail

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific GPCR-targeting Drug Product

Table 54. Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Merck Company Detail

Table 57. Merck Business Overview

Table 58. Merck GPCR-targeting Drug Product

Table 59. Merck Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 60. Merck Recent Development

Table 61. BD Biosciences Company Detail

Table 62. BD Biosciences Business Overview

Table 63. BD Biosciences GPCR-targeting Drug Product

Table 64. BD Biosciences Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 65. BD Biosciences Recent Development

Table 66. Molecular Devices Company Detail

Table 67. Molecular Devices Business Overview

Table 68. Molecular Devices GPCR-targeting Drug Product

Table 69. Molecular Devices Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 70. Molecular Devices Recent Development

Table 71. Promega Company Detail

Table 72. Promega Business Overview

Table 73. Promega GPCR-targeting Drug Product

Table 74. Promega Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 75. Promega Recent Development

Table 76. Qiagen Company Detail

Table 77. Qiagen Business Overview

Table 78. Qiagen GPCR-targeting Drug Product

Table 79. Qiagen Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 80. Qiagen Recent Development

Table 81. Abcam Company Detail

Table 82. Abcam Business Overview

Table 83. Abcam GPCR-targeting Drug Product

Table 84. Abcam Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 85. Abcam Recent Development

Table 86. Corning Company Detail

Table 87. Corning Business Overview

Table 88. Corning GPCR-targeting Drug Product

Table 89. Corning Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 90. Corning Recent Development

Table 91. Discoverx Company Detail

Table 92. Discoverx Business Overview

Table 93. Discoverx GPCR-targeting Drug Product

Table 94. Discoverx Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 95. Discoverx Recent Development

Table 96. Cisbio Company Detail

Table 97. Cisbio Business Overview

Table 98. Cisbio GPCR-targeting Drug Product

Table 99. Cisbio Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)

Table 100. Cisbio Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Global GPCR-targeting Drug Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global GPCR-targeting Drug Market Share by Type: 2022 VS 2029

Figure 3. Reagent Test Kit Features

Figure 4. Substrate Features

Figure 5. Global GPCR-targeting Drug Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 6. Global GPCR-targeting Drug Market Share by Application: 2022 VS 2029

Figure 7. Oncology Case Studies

Figure 8. Cardiovascular Case Studies

Figure 9. Central Nervous Case Studies

Figure 10. Other Case Studies

Figure 11. GPCR-targeting Drug Report Years Considered

Figure 12. Global GPCR-targeting Drug Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 13. Global GPCR-targeting Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 14. Global GPCR-targeting Drug Market Share by Region: 2022 VS 2029

Figure 15. Global GPCR-targeting Drug Market Share by Players in 2022

Figure 16. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2022)

Figure 17. The Top 10 and 5 Players Market Share by GPCR-targeting Drug Revenue in 2022

Figure 18. North America GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 19. North America GPCR-targeting Drug Market Share by Country (2018-2029)

Figure 20. United States GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. Canada GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Europe GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe GPCR-targeting Drug Market Share by Country (2018-2029)

Figure 24. Germany GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. France GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. U.K. GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. Italy GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Russia GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Nordic Countries GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Asia-Pacific GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Asia-Pacific GPCR-targeting Drug Market Share by Region (2018-2029)

Figure 32. China GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Japan GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. South Korea GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Southeast Asia GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. India GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Australia GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Latin America GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 39. Latin America GPCR-targeting Drug Market Share by Country (2018-2029)

Figure 40. Mexico GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. Brazil GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Middle East & Africa GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Middle East & Africa GPCR-targeting Drug Market Share by Country (2018-2029)

Figure 44. Turkey GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Saudi Arabia GPCR-targeting Drug Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. PerkinElmer Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 47. Thermo Fisher Scientific Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 48. Merck Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 49. BD Biosciences Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 50. Molecular Devices Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 51. Promega Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 52. Qiagen Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 53. Abcam Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 54. Corning Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 55. Discoverx Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 56. Cisbio Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global GPCR-targeting Drug Market Research Report 2023

Published Date: May 2023

Report Code: QYRE-Auto-22I14329

Global GPCR-targeting Drug Market Research Report 2023

FEATURED COMPANIES

GPCR-targeting Drug Market Size

GPCR-targeting Drug Market

Report Scope

Scope of GPCR-targeting Drug Market Report

Core Chapters

FAQ for this report

How fast is GPCR-targeting Drug Market market growing?

What is the GPCR-targeting Drug Market market size in 2029?

FEATURED COMPANIES

RELATED REPORTS